INFLUENCE OF PHYSICAL REHABILITATION ON SOCIAL NETWORKS AND QUALITY OF LIFE AMONG PEOPLE WITH PARKINSON’S DISEASE

• Authors: Lizoń Krzysztof , Cholewa Joanna , Uher Ivan
• Languages of publication: EN

Abstracts

Parkinson's Disease (PD) is the second most common neurodegenerative disease. Symptoms relate to the movement and cognitive sphere; they have a negative impact on the quality of life of people suffering from PD. Pharmacotherapy and rehabilitation slow the progression of the disease. The aim of the work was to determine the impact of physical rehabilitation on the level of social relations in the context of the quality of life of people with PD. 47 people with idiopathic PD were involved in the study, all were in the second stage of the disease according to the Hoehn & Yahr scale. The Courage Social Network Index (CSNI) was used to assess social relations. The scales: Quality of Life in Parkinson’s Disease 39 (PDQ-39), Medical Outcomes Study 36-item Short-Form Heath Survey (SF-36) and Parkinson’s Disease Quality of Life Questionnaire (PDQL) were applied in order to evaluate the quality of life of patients The subjects were divided into two groups: research and control. The research group took part in a rehabilitation program two times a week for 45 minutes for three months. The control group did not participate in any form of physical rehabilitation. The results of the research showed a significantly higher level of social bonds as well as quality of life of people with PD participating in physical rehabilitation. At the same time, a higher level of correlation between the level of social bonds and the level of quality of life was found in the research group. Therefore, the positive impact of physical rehabilitation on the level of social bonds and the quality of life of people with PD constituted the conclusion of the work.

Keywords

EN

Parkinson's disease; social networks; quality of life; rehabilitation

• Publisher: Politechnika Opolska. Wydział Wychowania Fizycznego i Fizjoterapii
• Journal: Journal of Physical Education & Health - Social Perspective
• Year: 2017
• Volume: 6
• Issue: 10
• Pages: 35-42

Dates

published

2017

Contributors

author

Lizoń Krzysztof

• The Jerzy Kukuczka Academy of Physical Education in Katowice, Department of Physiotherapy, Poland

author

Cholewa Joanna

• The Jerzy Kukuczka Academy of Physical Education in Katowice, Department of Physiotherapy, Poland

author

Uher Ivan

• P. J. Šafárik University in Košice, Institute of Physical Education and Sport, Slovak Republic

References

• 1. Brusse K, Zimdars S, Zalewski K, Steffen M (2005). Testing functional performance in people with Parkinson disease. Phys Ther, 2: 134–141.
• 2. Cholewa Joanna (2014): Rehabilitation procedures aimed at decreasing motor symptoms in Parkinson’s Disease. International Journal of Physical Medicine and Rehabilitation. S5-009.
• 3. Davie CA (2008). A review of Parkinson’s disease. Br Med Bull, 86: 109–127.
• 4. Ghorbani Saeedian R, Nagyova I, Krokavcova M, Skorvanek M, Rosenberger J, Gdovinova Z, Groothoff JW, van Dijk JP (2014). The role of social support in anxiety and depression among Parkinson’s disease patients. Disabil Rehabil, 36(24): 2044–2049.
• 5. Gupta A, Dawson VL, Dawson TM (2008). What causes cell death in Parkinson’s Disease? Ann Neurol, 64: 3–15.
• 6. Hobson P, Holden A, Meara J (1999). Measuring the impact of Parkinson’s disease with the Parkinson’s Disease Quality of Life questionnaire. Age Ageing, 28: 341–346.
• 7. Hoehn MM, Yahr MD (1967). Parkinsonism: Onset, progression and mortality. Neurology, 17: 427–442.
• 8. Jankovic J (2008). Parkinson’s disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry, 79: 368–376.
• 9. Jenkinson C, Heffernan C, Doll H, Fitzpatrick R (2006). The Parkinson’s Disease Questionnaire (PDQ-39): Evidence for a method of imputing missing data. Age Ageing, 35: 497–502.
• 10. Massano J, Bhatia PB (2012). Clinical Approach to Parkinson’s Disease: Features, Diagnosis, and Principles of Management. Cold Spring Harb Perspect Med, 2: 1-15.
• 11. Morimoto T, Shimbo T, Orav JE, Matsui K, Goto M, Takemura M, Hira K, Fukui T (2003). Impact of Social Functioning and Vitality on Preference for Life in Patients with Parkinson’s Disease. Mov Disord, 18: 171-175.
• 12. Ni M, Mooney K, Signorile JF (2016). Controlled pilot study of the effects of power yoga in Parkinson’s disease. Complement Ther Med, 25: 126-131.
• 13. Obeso JA, Rodriguez-Oroz MC, Goetz CG, Marin C, Kordower JH, Rodriguez M, Hirsch EC, Farrer M, Schapira AHV, Halliday G (2010). Missing pieces in the Parkinson’s disease puzzle. Nat Med, 16: 653-661.
• 14. Olanow CW, Stern MB, Sethi K (2009). The scientific and clinical basis for the treatment of Parkinson disease. Neurology, 72 (suppl 4): 1-136.
• 15. Radder D, Sturkenboom IH, van Nimwegen M, Keus SH, Bloem BR, de Vries NM (2017). Physical therapy and occupational therapy in Parkinson’s disease. Int J Neurosci, 127: 930-943.
• 16. RAND Corporation: 36-Item Short Form Survey Instrument (SF-36) [Internet]: Corporation, Santa Monica 2017.
• 17. Schrag A, Jahanshahi M, Quinn N (2000). How Does Parkinson’s Disease Affect Quality of Life? A Comparison With Quality of Life in the General Population. Mov Disord, 15: 1112–1118.
• 18. Shanahan J, Morris ME, Bhriain ON, Volpe D, Clifford AM (2017). Dancing and Parkinson’s disease: updates on this creative approach to therapy. Journal of Parkinsonism and Restless Legs Syndrome, 7: 43–53.
• 19. Shulman JM, De Jager PL, Feany MB (2011). Parkinson’s Disease: Genetics and Pathogenesis. Annu Rev Pathol Mech Dis, 6: 193–222.
• 20. Soleimani MA, Negarandeh R, Bastani F, Greysen R (2014). Disrupted social connectedness in people with Parkinson’s disease. Br J Community Nurs, 19: 136-141.
• 21. Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M (1998). a-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies. Proc Natl Acad Sci, 95: 6469–6473.
• 22. Takahashi K, Kamide N, Suzuki M, Fukuda M (2016). Quality of life in people with Parkinson’s disease: the relevance of social relationships and communication. J. Phys. Ther. Sci. 28: 541–546.
• 23. Tomlinson CL, Patel S, Meek C, Stowe R, Shah L, Sackley CM, Deane KHO, Herd CP, Wheatley K, Ives N (2012). Physiotherapy versus placebo or no intervention in Parkinson’s disease (Review). Cochrane Database of Systematic Reviews 2012, 8: CD002817
• 24. Weintraub D, Comella CL, Horn S (2008). Parkinson’s Disease — Part 1: Pathophysiology, Symptoms, Burden, Diagnosis, and Assessment. Am J Manag Care, 14: 40-48.
• 25. Wirdefeldt K, Adami HO, Cole P, Trichopoulos D, Mandel J (2011). Epidemiology and etiology of Parkinson’s disease: a review of the evidence. Eur J Epidemiol, 26: 1-58.
• 26. Zawisza K, Gałaś A, Tobiasz-Adamczyk B (2014). Polska wersja Courage Social Network Index - skali do oceny poziomu sieci społecznych. Gerontologia Polska, 22: 31-41.